AB
VRCA icon

Amalgamated Bank’s Verrica Pharmaceuticals VRCA Stock Holding History

Amalgamated Bank’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70
Closed – – 3157
2025
Q1 		$0 Hold
70
– – ﹤0.01% 2964
2024
Q4 		$0 Hold
70
– – ﹤0.01% 2982
2024
Q3 		$1K Hold
70
– – ﹤0.01% 2977
2024
Q2 		$5K Hold
70
– – ﹤0.01% 2815
2024
Q1 		$4K Sell
70
-226
-76% -$12.5K ﹤0.01% 2801
2023
Q4 		$22K Sell
296
-21
-7% -$863 ﹤0.01% 2612
2023
Q3 		$12K Hold
317
– – ﹤0.01% 2867
2023
Q2 		$18K Buy
+317
New +$19.2K ﹤0.01% 2802
2022
Q2 		– Sell
-213
Closed -$17K – 3213
2022
Q1 		$17K Buy
+213
New +$17.6K ﹤0.01% 2852

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Amalgamated Bank's VRCA Position: Q2 2025 in Review

Amalgamated Bank sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 70 shares.

Amalgamated Bank first reported a position in VRCA in Q1 2022 and held it in 9 quarters. The position peaked at $22K in Q4 2023. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Amalgamated Bank reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 70 Verrica Pharmaceuticals shares in Q2 2025.
  • Amalgamated Bank first reported a position in Verrica Pharmaceuticals in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's Verrica Pharmaceuticals position peaked at $22K in Q4 2023.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.